From Boltz-1 to Boltz-2: Did We Finally Bridge the Gap Between Structure and Affinity?
In modern biology, accurately simulating biomolecular interactions is a major difficulty. Our capacity to predict biomolecular complex structures has significantly improved with recent developments like AlphaFold3 and Boltz-1, yet these models are still unable to predict binding affinity, a crucial characteristic that underlies molecular function and therapeutic efficacy. Here, researchers from MIT introduce Boltz-2, a…
